LifeStance Health (LFST) Gross Profit (2024 - 2026)

LifeStance Health (LFST) has reported Gross Profit for 3 consecutive years, with $135.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit rose 23.81% year-over-year to $135.9 million; the TTM figure through Mar 2026 stood at $487.2 million (up 16.71% YoY), while the FY2025 annual figure was $461.1 million, up 14.59% from the prior year.
• Gross Profit grew to $135.9 million in Q1 2026 per LFST's latest filing, from $126.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $135.9 million in Q1 2026 and bottomed at $94.7 million in Q1 2024.
• Historically, Gross Profit has averaged $111.0 million across 3 years, with a median of $109.4 million in 2024.
• Annual changes were most pronounced in 2025 — Gross Profit gained 10.86% — and 2026, when it grew 23.81%.
• LifeStance Health's Gross Profit stood at $109.4 million in 2024, then gained by 15.41% to $126.3 million in 2025, then grew by 7.63% to $135.9 million in 2026.
• Business Quant data shows LFST's Gross Profit at $135.9 million in Q1 2026, $126.3 million in Q4 2025, and $116.6 million in Q3 2025.